The market prices SOLS as a $10B refrigerant company at ~10x EV/EBITDA. Inside it: the only US uranium conversion facility — a toll-road where every pound of American nuclear fuel must pass.
The Thesis in 30 Seconds
Honeywell spun off SOLS in October 2025. The market sees a refrigerant and specialty chemicals company. Hidden inside the “Electronic & Specialty Materials” segment is Metropolis Works — the only uranium hexafluoride (UF6) conversion facility in the United States, with an NRC license through 2060. Legacy conversion contracts written at depressed prices are repricing to current market rates — same cost structure, significantly higher revenue per unit. The nuclear segment alone could justify a premium multiple, but the market is pricing the entire company as a chemicals conglomerate.
The market classifies SOLS as a specialty chemicals company and values it at ~10x EV/EBITDA. The mispricing: inside the “Electronic & Specialty Materials” segment is a monopoly toll-road business where every kilogram of US nuclear fuel must be converted at Metropolis Works, Illinois — the only NRC-licensed UF6 conversion facility in the Western hemisphere outside of Canada and France. Legacy contracts signed when conversion prices were depressed are rolling off and repricing at significantly higher market rates with an identical cost structure. This is a pure margin expansion story hiding inside a conglomerate spinoff. Critical addition: The 72% refrigerant segment is not dead weight — data center cooling demand is creating a second AI exposure angle that could drive re-rating independently of the nuclear thesis.
SOLS was spun off from Honeywell in October 2025 as part of a three-way breakup. The market classified it as a “specialty chemicals” company — refrigerants, fluorine products, electronic materials. That classification misses the crown jewel entirely.
“There is no other path to enrichment in the United States. Every pound of nuclear fuel that enters an American reactor passed through a conversion facility first.”
— DOE Nuclear Fuel Working Group ReportTHE SPINOFF MISPRICING WINDOW
⚡ Spinoff dynamics: SOLS has been trading for ~4 months. Honeywell shareholders who didn’t want a chemicals company force-sold shares. Index funds that held Honeywell rebalanced out. This creates a mechanical mispricing window — the first full quarter of dedicated institutional ownership data (Q1 2026 filings in May) will reveal whether smart money is accumulating. That window is narrowing.
⚠ Timing risk: If May 13F filings show heavy institutional accumulation, the mispricing thesis weakens. The trade is better before dedicated ownership builds, not after.
Nuclear fuel goes through a mandatory sequence. Conversion is step 2 — there is no alternative pathway. Every reactor operator is a forced buyer.
“U.S. uranium conversion services are essential to maintaining a reliable domestic nuclear fuel supply chain and reducing dependence on foreign sources.”
— U.S. Department of Energy, Nuclear Fuel Working Group (2020)SOLS has been public for only ~4 months. It generates limited direct data points — 2 independent sources detected including institutional 13F positioning from 8 funds and failure-to-deliver activity. But the nuclear fuel ecosystem it operates within is one of the most data-rich themes in our dataset.
The companies that mine uranium, enrich it, and build the reactors that consume SOLS’s output are among the most active names in our convergence dataset:
| Company | Relationship to SOLS | Indicator Activity | Direction |
|---|---|---|---|
| Cameco (CCJ) | Upstream supplier + conversion competitor | Very High — 7 independent sources | Bullish |
| Centrus Energy (LEU) | Downstream — enriches SOLS’s UF6 output | High — 4 independent sources | Bullish |
| Constellation (CEG) | Largest US nuclear fleet — forced buyer | Moderate — multiple sources | Bullish |
| NuScale Power (SMR) | Next-gen reactors = new conversion demand | Detected | Bullish |
| Oklo (OKLO) | Advanced reactor — HALEU conversion demand | Detected | Bullish |
| Bloom Energy (BE) | Complementary power thesis (fuel cells) | High — multiple sources | Bullish |
| SOLS | Direct — too new for data | No activity (4-month old spinoff) | — |
THE ECOSYSTEM INDICATOR
CCJ shows the strongest convergence in our nuclear dataset — 7 independent indicator categories all pointing bullish simultaneously. Congressional trades, institutional accumulation, lobbying activity, and policy catalysts all converging. Every bullish indicator on uranium demand is an indirect indicator on conversion demand — which is all SOLS needs. The nuclear fuel cycle is sequential: more mining → more conversion → more enrichment. SOLS sits at the chokepoint.
MONITORING ACTIVE
SOLS has been added to our monitoring across All 34 data sources. Any congressional trades, institutional filings, or lobbying activity on SOLS will be detected and scored automatically. The first meaningful data will likely arrive with Q1 2026 13F filings in May — watch for dedicated nuclear fund accumulation.
SELL-SIDE MOMENTUM BUILDING
The wall of analyst indifference is cracking. RBC initiated coverage at Outperform with a $75 price target (vs ~$64 current). UBS maintains Buy. For a 4-month-old spinoff, two bullish initiations this quickly is notable — sell-side coverage typically takes 6–12 months post-spinoff. Analyst coverage is one of the key catalysts for resolving the segment visibility problem.
| Source | Actor | Direction | Value | Change | Key Detail |
|---|---|---|---|---|---|
| 13F: Point72 | Steve Cohen | Bullish | $86.6M | NEW (+100%) | 1,782,184 shares. Largest tracked position in SOLS. |
| 13F: Millennium | Israel Englander | Bullish | $87.8M | NEW (+100%) | 1,807,366 shares. Significant new position post-spinoff. |
| 13F: Two Sigma | John Overdeck | Bullish | $43.1M | NEW (+100%) | 888,210 shares. |
| 13F: Citadel | Ken Griffin | Bullish | $47.0M | NEW (+100%) | 687,067 shares common + 172,675 calls + 103,100 puts. |
| Lobbying (HON legacy) | Honeywell International | Bullish | $2,240,000 | — | Nuclear energy, defense, critical rare earth elements, refrigerant HFCs, AI/quantum. 6 registrants. |
| FTD | Market Makers | Bullish | $740,000 | — | 14,995 fails, 26 fail days. Persistent pattern, elevated volume. |
| DOD Contract (HON) | US Army | Bullish | $58,800,000 | — | AGT-1500 gas turbine engine platform modification. |
| Transcript | Q4 2025 (Feb 11) | Neutral | $987M rev | +8% YoY | Tone 6/10. Dividend initiated. Nuclear + electronic materials + refrigerants growth. |
All 13F Positions
100% NEW
Post-HON spinoff (Oct 2025)
Total 13F Exposure
$264M+
8 fund positions
Short Volume Ratio
36.9%
Lowest in portfolio
Full Convergence Data
The full alpha map — exact convergence scores, source-by-source breakdown, and real-time monitoring across all nuclear fuel chain participants.
Unlock with Pro| Segment | FY2025 | Mix | What | Thesis Role |
|---|---|---|---|---|
| Refrigerants (HFCs/HFOs) | ~$2.8B | 72% | Solstice brand next-gen refrigerants, legacy HFCs, fluorine products | AI cooling catalyst |
| Electronic & Specialty Materials | ~$1.1B | 28% | Nuclear (UF6 conversion), electronic-grade chemicals, specialty fluorines | Hidden monopoly |
“We see double-digit EBITDA growth in our nuclear business through the end of the decade, supported by a fully contracted backlog and expanding capacity at Metropolis.”
— SOLS Q4 2025 Earnings Call (Feb 11, 2026)THE DUAL AI EXPOSURE
Nuclear (28%): Data centers are driving a nuclear renaissance. Microsoft, Google, and Amazon have all signed nuclear PPAs. Every new reactor needs fuel. Every pound of fuel needs conversion. SOLS is the toll collector.
Refrigerants (72%): The refrigerant segment is not dead weight — it’s a second AI catalyst. Data center cooling is driving unprecedented demand for next-generation low-GWP refrigerants. SOLS’s Solstice product line is purpose-built for this transition. The HFC phase-down under the AIM Act (2024–2036) forces adoption of HFOs, where SOLS holds significant market share and manufacturing IP. The market could re-rate SOLS not because it discovers the nuclear monopoly, but because it discovers the refrigerant business has AI-driven pricing power too.
⚠ The Segment Visibility Problem
This is the single most important risk in the thesis. Nuclear revenue is buried inside “Electronic & Specialty Materials” at 28% of total revenue. The market cannot re-rate a business it cannot see.
The re-rating thesis requires visibility — either SOLS breaks nuclear out as a separate reporting segment, an analyst forces the question on an earnings call, or nuclear revenue grows large enough to be undeniable. Until then, the value stays hidden. This is the difference between “great thesis” and “great thesis that takes longer than you expect.”
Watch for: (1) Segment reporting changes in 10-K/10-Q filings, (2) Analyst coverage initiations that specifically mention nuclear conversion, (3) ConverDyn contract announcements that force revenue disclosure, (4) Earnings call Q&A where analysts press on nuclear margins. Early sign: RBC (Outperform, $75 PT) and UBS (Buy) have initiated — the wall of analyst indifference is cracking.
This is the core quantitative thesis: SOLS’s legacy conversion contracts were signed when spot conversion prices were depressed. Those contracts are rolling off and being replaced at significantly higher market rates — with an identical cost structure.
MANAGEMENT CONFIRMATION (FEB 11 EARNINGS CALL)
This is no longer just our inference — management explicitly confirmed the repricing thesis on the Q4 2025 call. Double-digit EBITDA CAGR through 2030 on nuclear, with a $2B backlog fully contracted. The cost base stays flat while conversion prices reset higher. The CEO stated this publicly. The thesis has moved from “what we believe” to “what the company is guiding.”
WHY THIS IS A TOLL ROAD, NOT A COMMODITY
Unlike uranium mining (commodity exposure to spot price), conversion is a processing service. SOLS doesn’t own the uranium — it converts it for a fee per kilogram. The input cost is energy and chemicals, not uranium. This means conversion margins expand when conversion prices rise, regardless of where uranium spot goes. It’s a toll road, not a mine.
UF6 Conversion Repricing Model
| Metric | Legacy (pre-2024) | Market Rate (2026) | Delta | Impact |
|---|---|---|---|---|
| UF6 Conversion Price | $8-12/kgU | $35-45/kgU | +3-4x | Pure margin expansion on same cost base |
| Metropolis Works Capacity | ~15,000 MTU | ~15,000 MTU | 0 | No capex needed — existing infrastructure |
| Contract Repricing Timeline | 5-10 yr terms | Rolling 2024-2030 | — | Each renewal reprices 3-4x higher |
| Est. Conversion Revenue | ~$150-180M | ~$400-550M | +$250-370M | Multi-year revenue acceleration |
EBITDA Bridge: If conversion revenue reprices from ~$165M to ~$475M midpoint (+$310M) at incremental margins of ~60-70% (fixed cost base, no new capex), this adds ~$185-215M to EBITDA over the repricing window. On a current EV of ~$4B, that’s a 5-6% yield improvement from conversion repricing alone — before accounting for nuclear new-build demand or HALEU conversion optionality.
Repricing Math & EBITDA Bridge
Specific per-kgU pricing, EBITDA bridge from legacy to market rates, capacity utilization modeling, and segment-level margin estimates.
Unlock with ProRefrigerant AI Cooling Cascade
AI data centers generate extreme heat densities. SOLS E-Cooling platform targets this as 3M Novec discontinues. Hyperscaler contract would re-rate SOLS from nuclear pure-play to dual-exposure. SOLS becomes sole qualified non-Chemours supplier.
Russia Sanctions Ratchet
Each sanctions escalation restricts Rosatom (~40% of global conversion). Western utilities scramble for non-Russian supply. Metropolis Works (only US facility, NRC license to 2060) captures overflow at market rates. Irreversible structural shift.
DOE Domestic Fuel Mandate Loop
HON lobbied $2.24M on nuclear energy priorities. DOE domestic fuel requirements for new SMRs create HALEU conversion demand. Only ConverDyn can supply domestically. Premium pricing at higher utilization absorbs fixed costs.
3 Additional Loops
Additional reinforcing loops — including the refrigerant AI cooling cascade, the Russia sanctions ratchet, and the DOE domestic fuel mandate loop.
Unlock with ProTheir advantage: Largest Western uranium producer. Port Hope conversion facility. Vertically integrated mine-to-conversion. More analyst coverage, larger market cap.
Why SOLS is different: Cameco is primarily a mining company — conversion is one segment among several. SOLS/ConverDyn is the only US-based converter, which matters for domestic fuel security mandates and “Buy American” provisions. US utilities with domestic sourcing requirements have one option.
Risk: Cameco expands Port Hope capacity, reducing SOLS’s pricing power.
Their advantage: Major global converter (Malvési/Pierrelatte), vertically integrated through enrichment and fuel fabrication. French state backing.
Why SOLS is different: Orano is not US-based and not publicly traded. For US utilities, importing from France adds transport, regulatory, and geopolitical friction. SOLS’s location advantage is geographic and regulatory.
Risk: Orano offers aggressive pricing to capture US market share.
Status: Russian enriched uranium import ban signed August 2024. TVEL/Rosatom conversion effectively removed from Western supply chain.
Why this matters for SOLS: Russia was previously the largest global converter. Sanctions removed the biggest competitor and created a structural supply deficit. Western converters (ConverDyn, Cameco, Orano) are absorbing displaced demand — directly benefiting SOLS pricing.
Risk: Sanctions relaxed or Russia routes through intermediaries (Kazakhstan, China).
Each of these risks has a specific downgrade trigger. Pro members see the exact conditions that would change our conviction score.
Only US UF6 conversion facility. NRC license through 2060. Forced buyers with no alternative domestic source. Rosatom sanctioned removes main competitor. Legacy contracts repricing = pure margin expansion. Dual AI exposure through nuclear power demand and data center cooling refrigerants.
Q4 earnings beat confirmed: $987M revenue (+8% YoY), double-digit nuclear growth, $2B backlog contracted through 2030. CEO guiding double-digit EBITDA CAGR on nuclear. RBC and UBS both bullish. Still early as independent company, but the first earnings print validated the thesis.
Upgraded from 6.5 after Q4 earnings confirmed nuclear growth trajectory and management explicitly guided the repricing thesis.
Stock popped 15% on Q4 earnings — the market is starting to notice. Spinoff forced-selling window narrowing. Sell-side coverage building (RBC Outperform $75, UBS Buy). Nuclear renaissance catalysts accelerating. AIM Act HFC phase-down active. Q1 2026 13F filings (May) are the next major data point.
Thesis Conviction
8.1/10
How strong is the structural case? Very. The only US uranium conversion facility, NRC license through 2060, forced buyers at every step, legacy contracts repricing at identical cost, and now management explicitly guiding double-digit nuclear EBITDA CAGR through 2030. The structural parallels to RMBS (monopoly tollbooth hiding in plain sight) are exact.
Trade Attractiveness
7.2/10
Upgraded after Q4 earnings confirmed the thesis. Stock popped 15%, sell-side initiating bullish, management guiding nuclear EBITDA CAGR. The spinoff mispricing window is narrowing but still open. Segment opacity remains the key friction — but analyst coverage is now forcing visibility.
Why the gap between conviction and execution matters: The structural case (8.5) vs execution score (7.0) is a 1.5-point spread. Narrowed from 2.0 after Q4 earnings confirmed nuclear growth and management guided the repricing. The monopoly is real, the economics are extraordinary, and now management is publicly guiding the repricing. The remaining gap reflects segment opacity — until nuclear breaks out as a visible reporting segment, the full re-rating is delayed. But with sell-side coverage building and the 15% earnings pop, the market is beginning to look.
Score Review — Feb 18, 2026
Score reviewed at 8.1 — HELD. 13F pipeline fix revealed 8 institutional positions, all NEW post-Honeywell spinoff (Oct 2025). However, all holders are quant/multi-strategy (Griffin, Millennium, Cohen, Two Sigma) — expected index rebalancing after spinoff, not thesis-aligned accumulation. Convergence improved from 0 to 32.7/100 with 2 sources. Structural monopoly thesis (only US UF6 conversion facility) remains the primary score driver. Will re-evaluate when Q1 2026 13F filings arrive May 2026 for thesis-aligned fund activity.
We monitor 8 specific upgrade and downgrade triggers for SOLS in real time.
Upgrade Triggers (5)
1. Nuclear Segment Reported Separately
Closes structural-to-execution gap immediately.
2. Hyperscaler E-Cooling Contract
Validates AI cooling thesis. Re-rates to dual-exposure.
3. HALEU Conversion Contract
New TAM at premium pricing. Metropolis is the only candidate.
4. Russia Sanctions Escalation
Each Rosatom restriction diverts demand to SOLS.
5. 13F Accumulation > $500M
Currently $264M across 4 funds. Doubling = broad conviction.
Downgrade Triggers (5)
1. Rosatom Sanctions Relief
Re-introduces Russian supply, crashing spot prices.
2. Metropolis Downtime > 30 Days
Single facility risk. Directly impacts revenue.
3. E-Cooling Revenue < $50M by 2027
AI cooling thesis not materializing.
4. Conversion Spot < $20/kgU
Repricing thesis collapses. Currently $35-45.
5. Transition Costs Sustained > 2Q
Spin-off costs impair margins longer than expected.
Upgrade / Downgrade Triggers
Specific conditions that would change our conviction score — including segment reporting changes, 13F accumulation thresholds, conversion price milestones, and reactor demand indicators.
Unlock with ProCurrent: ~$64/share, ~$10.2B market cap. Morningstar fair value estimate: $97.
| Segment | Est. Revenue | Multiple | Implied Value | Peer Basis |
|---|---|---|---|---|
| Nuclear (UF6 Conversion) | $400-550M | 6-8x EV/Rev | $2.4-4.4B | CCJ (14-17x), LEU (33x). Discount for no segment visibility. |
| Electronic Materials | $250-300M | 3-4x | $750M-1.2B | Specialty chemicals peers (3-5x). |
| Refrigerants (inc. E-Cooling) | $200-250M | 3-5x | $600M-1.25B | Chemours peer, premium for AI cooling. |
| Total Sum-of-Parts | $3.75-6.85B | vs current EV ~$4B. Upside if nuclear segment becomes visible. |
The wide range ($3.75-6.85B) reflects the structural-to-execution gap. At the low end, SOLS trades at fair value. At the high end (CCJ-like nuclear multiple + E-Cooling premium), there’s 70%+ upside. The key unlock: separate nuclear segment reporting. Until investors can see conversion economics independently, the market applies a conglomerate discount.
Valuation Multiples & Sum-of-Parts
Full sum-of-parts analysis, segment-level multiples, peer comparison with CCJ (14–17x) and LEU (33x), and probability-weighted scenario targets.
Unlock with ProRefrigerant Company or Nuclear Monopoly?
The market values SOLS at ~10x EV/EBITDA — a chemicals company multiple. But consider: Cameco trades at 14–17x, Centrus Energy (LEU) trades at 33x, and NuScale at an even higher premium. If the nuclear conversion business were valued independently at nuclear peer multiples, the segment alone could be worth more than the market currently assigns to SOLS’s nuclear revenue contribution. Add the refrigerant business at a chemicals multiple, and the sum-of-parts significantly exceeds the current blended valuation.
Scenario Analysis (12–18 Month View)
▲ BULL CASE
Significant Upside
if nuclear re-rating occurs
Probability: 25% — requires market to see what’s hidden. Catalyst-dependent but structurally sound.
→ BASE CASE
Moderate Upside
steady repricing + visibility
Probability: 50% — does not require market to re-categorize. Earnings growth alone drives returns.
▼ BEAR CASE
Meaningful Downside
if execution falters
Probability: 25% — requires multiple negatives simultaneously. Single plant risk is the most plausible bear catalyst.
| Scenario | 12-18mo Target | Probability | Weighted Return |
|---|---|---|---|
| Bull: Segment Visibility + HALEU | $75-90 | 20% | +11.0% |
| Base: Steady Repricing | $55-65 | 40% | +5.8% |
| Bear: Sanctions Relief + Execution | $30-38 | 25% | -8.8% |
| Expected Value | 100% | +20.8% |
Trade Expression
Primary: Long common equity, 3-5% portfolio. Post-spinoff dislocation creates entry opportunity as HON holders who received SOLS shares exit mechanically. Catalyst timing: Next 2-3 quarters as conversion contracts reprice. Hedge: Pair with short CCJ to isolate SOLS-specific alpha (conversion monopoly vs CCJ’s mining exposure).
Expected Value & Trade Expression
Full probability-weighted expected value, entry zones, position sizing framework, and optimal trade expression for the SOLS thesis.
Unlock with ProLEAPS Mispricing Analysis
Growth Profile
Structural Monopoly
12mo Gap
+27.3pp
Recommendation
STRONG BUY LEAPS
SOLS has structural pricing power that options markets systematically undervalue. Monopoly repricing and forced-buyer dynamics create a floor that narrows the real bear case, but options pricing doesn't distinguish between structural and cyclical downside risk.
| HORIZON | Market Bull % | Our Bull % | GAP | MISPRICING | LEAPS STRIKE | LEVERAGE |
|---|---|---|---|---|---|---|
| 6 months | 5.2% | 38.0% | +32.8pp | ████████████████ | $55 | 3.4x |
| 12 months | 10.7% | 38.0% | +27.3pp | █████████████ | $55 | 2.6x |
| 18 months | 14.1% | 36.0% | +21.9pp | ██████████ | $55 | 2.1x |
Methodology: Bayesian posterior probability (log-odds, self-calibrating, calibration round 0) vs Black-Scholes implied probability N(d2). Growth profile shaping applied per company type. Market P(bull) = implied probability of reaching $110 (bull target midpoint). LEAPS strikes at ~75% of current price for deep ITM exposure. This is not investment advice.
LEAPS MISPRICING
Time-dependent Bayesian probability vs options market pricing. See where LEAPS are structurally underpriced for geometric compounders.
Unlock LEAPS AnalysisNuclear fuel follows a mandatory sequential process. SOLS/ConverDyn sits at Step 2 — the conversion chokepoint between mining and enrichment. There is no way to skip this step.
| Step | Process | Key Players | SOLS Role |
|---|---|---|---|
| 1. Mining | U3O8 (yellowcake) from ore | Cameco (CCJ), Kazatomprom, Uranium Energy (UEC) | Upstream supplier |
| 2. Conversion | U3O8 → UF6 (hex) | ConverDyn/SOLS (Metropolis, IL) | Monopoly |
| 3. Enrichment | UF6 → LEU (3–5% U-235) | Centrus (LEU), Urenco, Orano | Downstream customer |
| 4. Fabrication | LEU → fuel assemblies | Westinghouse, Framatome, GNF | N/A |
| 5. Reactor | Fuel → electricity | Constellation (CEG), Duke, Southern, Exelon | End demand driver |
| Facility | Country | Operator | Status |
|---|---|---|---|
| Metropolis Works | United States | SOLS / ConverDyn | Active — Expanding |
| Port Hope | Canada | Cameco (CCJ) | Active |
| Malvési / Pierrelatte | France | Orano | Active |
| TVEL facilities | Russia | Rosatom | Sanctioned |
| CNNC facilities | China | CNNC | Domestic only |
Conversion Supply Chain Analysis
| Facility | Operator | Capacity (MTU/yr) | Status | Sanctions Impact |
|---|---|---|---|---|
| Metropolis Works (US) | SOLS / ConverDyn | ~15,000 | Active, NRC license to 2060 | Sole US facility. Beneficiary. |
| Pierrelatte (France) | Orano | ~14,000 | Active | Western ally. Neutral. |
| Springfields (UK) | Westinghouse | ~6,000 | Limited capacity | Neutral. |
| Seversk (Russia) | TVEL / Rosatom | ~12,500 | Sanctioned | Restricted from Western contracts. |
| Angarsk (Russia) | TVEL / Rosatom | ~5,000 | Sanctioned | Restricted. |
Global conversion capacity ex-Russia is ~35,000 MTU/yr against demand of ~50,000+ MTU/yr and growing (new reactor builds + SMRs). This structural deficit is what drives the 3-4x price increase from legacy rates. Metropolis Works is the only US conversion facility with an NRC license valid through 2060 — there is no US alternative.
Full Supply Chain Analysis
Detailed conversion pricing curves, ConverDyn partnership economics, capacity utilization modeling, customer base analysis, and HALEU conversion opportunity sizing.
Unlock with ProThe 72% refrigerant segment is not dead weight. SOLS owns the patents and manufacturing capacity for the exact cooling fluids that next-generation AI data centers physically require. This creates a second, independent AI exposure angle beyond nuclear.
Traditional data centers use air cooling. AI-density racks at 120kW+ cannot. SOLS’s Solstice E-Cooling platform uses two-phase immersion — the fluid boils on contact with hot GPUs, absorbing vastly more heat through latent heat of vaporization.
| Metric | Air Cooling | Solstice Two-Phase |
|---|---|---|
| Max Rack Density | 15–40 kW | 200 kW+ |
| Cooling Energy Use | 30–40% of total power | <5% of total power |
| Water Usage | Millions of gallons/year | Near zero (closed-loop) |
| Noise | High (massive fans) | Silent |
At Blackwell-class compute density (120kW+ per rack), air cooling is physically impossible. SOLS owns the coolant that makes the 2026-era data center possible.
This transition is not optional. The AIM Act (US) and F-Gas regulations (EU) are mandating the phase-out of legacy HFC refrigerants with high Global Warming Potential. SOLS holds the patents and manufacturing capacity for the low-GWP HFO (Hydrofluoroolefin) replacements.
In the physical layer of the AI trade: if the world wants Blackwell-class compute density, it physically cannot use 2010-era air cooling. SOLS owns both sides of the energy equation — the nuclear fuel that powers the reactors feeding data centers, and the cooling fluid that keeps the GPUs alive. This dual exposure is unique in the market and entirely unpriced by consensus.
AI Cooling Market Analysis
| Supplier | Product | Market Position | AI DC Suitability | Outlook |
|---|---|---|---|---|
| SOLS (E-Cooling) | Next-gen immersion fluids | Emerging (#3) | High — designed for GPU-density heat | Growing. 3M exit creates void. |
| Chemours (CC) | Opteon immersion fluids | Market leader (#1) | High | Stable. PFAS regulatory risk. |
| 3M (Novec) | Novec 7000 series | DISCONTINUED | — | Exiting 2025. Creates supply void. |
| Solvay | Galden fluids | Niche (#4) | Medium | Limited scale-up capacity. |
The AI data center cooling market is projected to grow from ~$2B (2025) to $8-12B by 2030 as GPU power densities make traditional air cooling insufficient. 3M’s Novec exit creates a qualified-supplier vacuum that SOLS E-Cooling is positioned to fill. If SOLS captures even 10-15% of the immersion cooling market by 2028, that’s $200-360M in incremental revenue at specialty chemical margins (40-50% gross). This is the hidden growth engine that most nuclear-focused analysts are missing.
Cooling Market Share & Revenue Model
SOLS market share vs Chemours and 3M Novec (discontinued), E-Cooling platform revenue estimates, hyperscaler contract pipeline, and cooling segment margin modeling.
Unlock with ProFramework Context
SOLS sits at Layer 4 (Power Wall) of the AI Infrastructure Bottleneck Framework — the nuclear fuel conversion chokepoint that powers the reactors feeding AI data centers. As the power bottleneck intensifies and hyperscalers sign nuclear PPAs, SOLS’s toll-road position strengthens automatically.
Read the Full Framework →Primary Sources
Nuclear & Conversion
Regulatory & Policy
Market Data & Peers
Competitive Intelligence